Both in Pharmaceuticals
Ocular Therapeutix vs Kailera Therapeutics
Over the past year OCUL returned −30.6% and KLRA returned −6.2%; their daily moves had a correlation of 0.29.
OCUL −30.6% KLRA −6.2%Growth of $1, one year, split-adjusted
| Metric | OCUL | KLRA |
|---|---|---|
| Price | $7.28 | $13.08 |
| Market cap | $1.60B | $1.70B |
| Today | +8.33% | −0.42% |
| 1 month | −7.5% | +19.0% |
| 6 months | −21.0% | — |
| Year to date | −40.0% | — |
| 1 year | −37.0% | — |
| Revenue growth (YoY) | +0.1% | — |
| Gross margin | 85.1% | — |
| Net margin | −584.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 30.7× | — |
| Net cash | $525.8M | $916.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.8% | — |
| Short % of float | 15.1% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).